On August 26, 2022, Viracta Therapeutics, Inc. (the Company) and Silicon Valley Bank (SVB) entered into a First Amendment (the First Amendment) to that certain Loan and Security Agreement dated as of November 4, 2021 (the Loan Agreement). The First Amendment amends the period for the Company to draw down the second tranche of $20.0 million under the Loan Agreement to the period commencing on October 1, 2022, and ending on the earlier to occur
of (i) December 30, 2022, and (ii) the occurrence of an event of default under the Loan Agreement, as amended.